Related Experiment Videos
mu-Opioid receptor mRNA expression in the rat CNS: comparison to mu-receptor binding
A Mansour1, C A Fox, R C Thompson
1Mental Health Research Institute, University of Michigan, Ann Arbor 48109-0720.
Abstract:
The distribution of cells expressing mu-receptor mRNA and mu-receptor binding sites were compared in brain and spinal cord tissue sections using a combination of in situ hybridization and receptor autoradiographic techniques. mu-Receptor mRNA was visualized with a 35S-labeled cRNA probe directed to transmembrane III-VI of the rat mu-receptor, while mu-receptor binding sites were labeled with the mu-selective ligand [3H]DAMGO. A high correspondence between the mu-receptor mRNA and receptor binding distributions was observed in the nucleus of the accessory olfactory bulb, anterior olfactory nuclei, striatal patches of the nucleus accumbens and caudate-putamen, endopiriform nucleus, claustrum, diagonal band of Broca, globus pallidus, ventral pallidum, bed nucleus of stria terminalis, most thalamic nuclei, medial and posteriocortical medial amygdala, lateral, dorsomedial, posterior and mammillary nuclei of the hypothalamus, presubiculum, subiculum, rostral interpeduncular nucleus, median raphe, inferior colliculus, parabrachial nucleus, locus coeruleus, central grey, nucleus ambiguus, nucleus of the solitary tract, nucleus gracilis, nucleus cuneatus, and the dorsal motor nucleus of vagus. Differences in mu-receptor mRNA and receptor binding distributions were observed in several regions, including the olfactory bulb, cortex, hippocampus, superior colliculus, spinal trigeminal nucleus, cochlear nucleus and spinal cord, and may be due to mu-receptor transport to presynaptic terminals.
Insights
Researchers mapped mu-receptor mRNA and binding sites in the brain and spinal cord. High correspondence was found, with some differences possibly due to receptor transport.
Area of Science:
- Neuroscience
- Molecular Biology
Background:
- The mu-opioid receptor is a key target for pain management and addiction therapies.
- Understanding its distribution is crucial for developing targeted therapeutics.
Purpose of the Study:
- To compare the distribution of mu-receptor mRNA and mu-receptor binding sites in the rat brain and spinal cord.
- To identify regions with correspondence and discrepancies between mRNA and binding site localization.
Main Methods:
- In situ hybridization to visualize mu-receptor mRNA using a 35S-labeled cRNA probe.
- Receptor autoradiography to label mu-receptor binding sites with [3H]DAMGO.
Main Results:
- High correspondence between mu-receptor mRNA and binding sites was observed in numerous brain regions, including the olfactory bulb, striatum, thalamus, and hypothalamus.
- Differences were noted in areas like the cortex, hippocampus, and spinal cord, potentially indicating presynaptic mu-receptor transport.
Conclusions:
- The study provides a detailed map of mu-receptor expression and binding in the rat central nervous system.
- Discrepancies suggest complex regulation and transport mechanisms for mu-opioid receptors.